Company: HCTI
Filing Date: 2025-03-05
Form Type: PRE 14C
Source: 0001213900-25-020571
Chunk: 17

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-05
Form: PRE 14C
Chunk 17
---
 (i) the closing price of the common
stock immediately preceding the signing of the binding agreement for the issuance of such securities and (ii) the average closing price
of the common stock for the five trading days immediately preceding the signing of the binding agreement for the issuance of such securities.
Because of Nasdaq Listing Rule 5635(d), the Purchase Warrants provide that they may not be exercised, and therefore have no value, until
the effective date of stockholder approval of their exercise. In determining whether an offering qualifies as a public offering, Nasdaq
considers all relevant factors, including the extent of any discount to market price. In determining discount, Nasdaq can attribute a
value to each warrant that contains an alternative cashless exercise Nasdaq could attribute a value of for each warrant that would fully
discount the securities being offered. In order to ensure that the Unit offering qualified as a public offering under Rule 5635 due to
the value attributable to the Purchase Warrants, the Purchase Warrants provide that they may not be exercised — and
therefore have no value — until stockholder approval of their exercise is obtained and is effective.

Interest of Certain Persons in Matters to Be Acted Upon

No director or executive officer has any substantial
interest, direct or indirect, by security holdings or otherwise, in this Proposal that is not shared by all of our other stockholders.

<div align='center'>10

ACTIONS AUTHORIZED AND APPROVED</div>

The actions that were taken by the Company’s
Board of Directors and by its Majority Stockholder(s) were the authorization and approval of the Corporate Actions, respectively.

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information with
respect to the beneficial ownership of our common stock and our Series A Super Voting Preferred Stock, our only outstanding classes of
capital stock having the right to vote on this matter, known by us as of the Record Date, by:

| ● | each person or entity known by us to be the beneficial owner of more 
 than 5% of our common stock;                                         |
| ● | each of our directors;                                               |
| ● | each of our executive officers; and                                  |
| ● | all of our directors and executive officers as a group.              |

Beneficial ownership of the voting stock is determined
in accordance with the rules of the SEC and includes any shares of Company voting stock over which a person exercises sole or shared
v